Core Insights - On November 3, Chao Yan Co., Ltd. saw a stock increase of 1.14% with a trading volume of 46.31 million yuan [1] - The company reported a financing buy-in of 6.08 million yuan and a net financing buy of 2.97 million yuan on the same day [1] - As of November 3, the total financing and securities lending balance for Chao Yan Co. was 93.82 million yuan [1] Financial Performance - For the period from January to September 2025, Chao Yan Co. achieved a revenue of 254 million yuan, a year-on-year decrease of 2.90% [2] - The net profit attributable to shareholders for the same period was 88.94 million yuan, reflecting a year-on-year decline of 3.66% [2] - Cumulative cash dividends paid by the company since its A-share listing amounted to 43.69 million yuan [2] Shareholder Structure - As of September 30, 2025, the number of shareholders for Chao Yan Co. was 17,000, a decrease of 23.90% from the previous period [2] - The largest circulating shareholder is Huabao Zhongzheng Medical ETF, holding 1.52 million shares, down by 388,200 shares from the previous period [3] - New institutional shareholders include Yuanxin Yongfeng Medical Health A, holding 650,100 shares [3]
超研股份11月3日获融资买入608.35万元，融资余额9359.73万元